Company & Sponsor Intelligence

New York Institute of Technology

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting0

Completed3

Countries1

Therapeutic footprint

parkinsons

Indexed studies

NCT01636011Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease
parkinsons · United StatesNA

NCT03307161Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia
parkinsons · United StatesNA

NCT03622840Impact of Individual Cognitive Remediation for Parkinson's Disease
parkinsons · United StatesNA

NCT01676103The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease
parkinsons · United StatesPHASE1, PHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →